{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:24:02Z","timestamp":1794385442751,"version":"4.9.0"},"reference-count":100,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2024,2,14]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>COPD is a major healthcare problem and cause of mortality worldwide. COPD patients at increased mortality risk are those who are more symptomatic, have lower lung function and lower diffusing capacity of the lung for carbon monoxide, decreased exercise capacity, belong to the emphysematous phenotype and those who have concomitant bronchiectasis. Mortality risk seems to be greater in patients who experience COPD exacerbations and in those who suffer from concomitant cardiovascular and\/or metabolic diseases. To predict the risk of death in COPD patients, several composite scores have been created using different parameters. In previous years, large studies (also called mega-trials) have evaluated the efficacy of different therapies on COPD mortality, but until recently only nonpharmaceutical interventions have proven to be effective. However, recent studies on fixed combinations of triple therapy (long-acting \u03b2-agonists, long-acting muscarinic antagonists and inhaled corticosteroids) have provided encouraging results, showing for the first time a reduction in mortality compared to dual therapies. The aim of the present review is to summarise available data regarding mortality risk in COPD patients and to describe pharmacological therapies that have shown effectiveness in reducing mortality.<\/jats:p>","DOI":"10.1183\/23120541.00850-2023","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T17:25:15Z","timestamp":1709832315000},"page":"00850-2023","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Mortality prevention as the centre of COPD management"],"prefix":"10.1183","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9708-3241","authenticated-orcid":false,"given":"Andriana I.","family":"Papaioannou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Hillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios","family":"Loukides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Vassilakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"2024101712192036000_10.3.00850-2023.1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease . Global Strategy for the Diagnosis, Management and Prevention of COPD. 2023. http:\/\/goldcopd.org. Date last accessed: 23 November 2022."},{"key":"2024101712192036000_10.3.00850-2023.2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1164\/rccm.202005-1990OC","article-title":"Prevalence and population-attributable risk for chronic airflow obstruction in a large multinational study","volume":"203","author":"Burney","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101712192036000_10.3.00850-2023.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1900500"},{"key":"2024101712192036000_10.3.00850-2023.4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S2213-2600(18)30002-X","article-title":"Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study","volume":"6","author":"Gedebjerg","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024101712192036000_10.3.00850-2023.5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-4-200502150-00005"},{"key":"2024101712192036000_10.3.00850-2023.6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1001\/jama.2020.4437","article-title":"Association between initiation of pulmonary rehabilitation after hospitalization for COPD and 1-year survival among Medicare beneficiaries","volume":"323","author":"Lindenauer","year":"2020","journal-title":"JAMA"},{"key":"2024101712192036000_10.3.00850-2023.7","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0718-1"},{"key":"2024101712192036000_10.3.00850-2023.8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.78.3.419"},{"key":"2024101712192036000_10.3.00850-2023.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)91970-X"},{"key":"2024101712192036000_10.3.00850-2023.10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2213-2600(14)70153-5","article-title":"Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial","volume":"2","author":"K\u00f6hnlein","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024101712192036000_10.3.00850-2023.11","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.108274"},{"key":"2024101712192036000_10.3.00850-2023.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030287"},{"key":"2024101712192036000_10.3.00850-2023.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713901"},{"key":"2024101712192036000_10.3.00850-2023.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916046"},{"key":"2024101712192036000_10.3.00850-2023.15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1164\/rccm.201707-1363OC","article-title":"Comparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease reports. Impact on grouping and outcomes","volume":"197","author":"Cabrera L\u00f3pez","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101712192036000_10.3.00850-2023.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2005.03.035"},{"key":"2024101712192036000_10.3.00850-2023.17","doi-asserted-by":"crossref","first-page":"106471","DOI":"10.1016\/j.rmed.2021.106471","article-title":"Mortality risk attributable to classification of chronic obstructive pulmonary disease and reduced lung function: a 21-year longitudinal cohort study","volume":"184","author":"Guo","year":"2021","journal-title":"Respir Med"},{"key":"2024101712192036000_10.3.00850-2023.18","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00146012"},{"key":"2024101712192036000_10.3.00850-2023.19","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.chest.2021.04.033","article-title":"Clinical and prognostic impact of low diffusing capacity for carbon monoxide values in patients with Global Initiative for Obstructive Lung Disease I COPD","volume":"160","author":"de-Torres","year":"2021","journal-title":"Chest"},{"key":"2024101712192036000_10.3.00850-2023.20","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2836"},{"key":"2024101712192036000_10.3.00850-2023.21","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1164\/rccm.201508-1653OC","article-title":"The 6-minute-walk distance test as a chronic obstructive pulmonary disease stratification tool. Insights from the COPD Biomarker Qualification Consortium","volume":"194","author":"Celli","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101712192036000_10.3.00850-2023.22","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.040527"},{"key":"2024101712192036000_10.3.00850-2023.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021322"},{"key":"2024101712192036000_10.3.00850-2023.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61301-5"},{"key":"2024101712192036000_10.3.00850-2023.25","doi-asserted-by":"publisher","DOI":"10.4104\/pcrj.2012.00054"},{"key":"2024101712192036000_10.3.00850-2023.26","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00012408"},{"key":"2024101712192036000_10.3.00850-2023.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909883"},{"key":"2024101712192036000_10.3.00850-2023.28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2213-2600(17)30207-2","article-title":"Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort","volume":"5","author":"Han","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024101712192036000_10.3.00850-2023.29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1517\/14656560902740804","article-title":"UPLIFT study: the effects of long-term therapy with inhaled tiotropium in chronic obstructive pulmonary disease. Evaluation of: Tashkin DP, Celli B, Senn S et al.: a 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med (2008) 359(15): 1543\u20131554","volume":"10","author":"Antoniu","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"2024101712192036000_10.3.00850-2023.30","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201309-305OC"},{"key":"2024101712192036000_10.3.00850-2023.31","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200708-1290OC"},{"key":"2024101712192036000_10.3.00850-2023.32","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00079409"},{"key":"2024101712192036000_10.3.00850-2023.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200310-1443OC"},{"key":"2024101712192036000_10.3.00850-2023.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2019.12.014"},{"key":"2024101712192036000_10.3.00850-2023.35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2029"},{"key":"2024101712192036000_10.3.00850-2023.36","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201711-2239OC"},{"key":"2024101712192036000_10.3.00850-2023.37","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s11606-018-4518-3","article-title":"Incidence of acute cardiovascular event after acute exacerbation of COPD","volume":"33","author":"Goto","year":"2018","journal-title":"J Gen Intern Med"},{"key":"2024101712192036000_10.3.00850-2023.38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12931-018-0944-3","article-title":"Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial","volume":"19","author":"Watz","year":"2018","journal-title":"Respir Res"},{"key":"2024101712192036000_10.3.00850-2023.39","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1164\/rccm.201605-1014OC","article-title":"Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease","volume":"195","author":"Dransfield","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101712192036000_10.3.00850-2023.40","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00166606"},{"key":"2024101712192036000_10.3.00850-2023.41","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00038814"},{"key":"2024101712192036000_10.3.00850-2023.42","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2011-201518"},{"key":"2024101712192036000_10.3.00850-2023.43","doi-asserted-by":"crossref","first-page":"636","DOI":"10.21037\/jtd.2017.03.34","article-title":"One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease","volume":"9","author":"Garc\u00eda-Sanz","year":"2017","journal-title":"J Thorac Dis"},{"key":"2024101712192036000_10.3.00850-2023.44","doi-asserted-by":"crossref","first-page":"e114866","DOI":"10.1371\/journal.pone.0114866","article-title":"In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study","volume":"9","author":"Ho","year":"2014","journal-title":"PLoS One"},{"key":"2024101712192036000_10.3.00850-2023.45","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1164\/rccm.201709-1852OC","article-title":"Risk trajectories of readmission and death in the first year after hospitalization for chronic obstructive pulmonary disease","volume":"197","author":"Lindenauer","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101712192036000_10.3.00850-2023.46","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201710-2029OC"},{"key":"2024101712192036000_10.3.00850-2023.47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006171"},{"key":"2024101712192036000_10.3.00850-2023.48","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.rmed.2014.12.001","article-title":"Subjects with COPD and productive cough have an increased risk for exacerbations and death","volume":"109","author":"Lindberg","year":"2015","journal-title":"Respir Med"},{"key":"2024101712192036000_10.3.00850-2023.49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024101712192036000_10.3.00850-2023.50","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201201-0034OC"},{"key":"2024101712192036000_10.3.00850-2023.51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12931-017-0512-2","article-title":"Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD","volume":"18","author":"Westerik","year":"2017","journal-title":"Respir Res"},{"key":"2024101712192036000_10.3.00850-2023.52","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-218333"},{"key":"2024101712192036000_10.3.00850-2023.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2005.04.008"},{"key":"2024101712192036000_10.3.00850-2023.54","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2024101712192036000_10.3.00850-2023.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.05.001"},{"key":"2024101712192036000_10.3.00850-2023.56","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0057-2018"},{"key":"2024101712192036000_10.3.00850-2023.57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063070"},{"key":"2024101712192036000_10.3.00850-2023.58","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1164\/rccm.201911-2207OC","article-title":"Reduction in all-cause mortality with fluticasone furoate\/umeclidinium\/vilanterol in patients with chronic obstructive pulmonary disease","volume":"201","author":"Lipson","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101712192036000_10.3.00850-2023.59","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1513\/pats.200410-051SF","article-title":"Clinical approach to patients with chronic obstructive pulmonary disease and cardiovascular disease","volume":"2","author":"Rennard","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"2024101712192036000_10.3.00850-2023.60","doi-asserted-by":"publisher","DOI":"10.1177\/1753465817750524"},{"key":"2024101712192036000_10.3.00850-2023.61","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamainternmed.2017.7720","article-title":"Association of cardiovascular risk with inhaled long-acting bronchodilators in patients with chronic obstructive pulmonary disease: a nested case\u2013control study","volume":"178","author":"Wang","year":"2018","journal-title":"JAMA Intern Med"},{"key":"2024101712192036000_10.3.00850-2023.62","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2499"},{"key":"2024101712192036000_10.3.00850-2023.63","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-208412"},{"key":"2024101712192036000_10.3.00850-2023.64","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2013-0085"},{"key":"2024101712192036000_10.3.00850-2023.65","doi-asserted-by":"crossref","first-page":"14003","DOI":"10.1038\/npjpcrm.2014.3","article-title":"Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial","volume":"24","author":"Troosters","year":"2014","journal-title":"NPJ Prim Care Respir Med"},{"key":"2024101712192036000_10.3.00850-2023.66","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMoa2204752","article-title":"Bronchodilators in tobacco-exposed persons with symptoms and preserved lung function","volume":"387","author":"Han","year":"2022","journal-title":"N Engl J Med"},{"key":"2024101712192036000_10.3.00850-2023.67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509283331301"},{"key":"2024101712192036000_10.3.00850-2023.68","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1001\/jama.2017.4451","article-title":"Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial","volume":"317","author":"Murphy","year":"2017","journal-title":"JAMA"},{"key":"2024101712192036000_10.3.00850-2023.69","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1159\/000515323","article-title":"Reduction in hospitalizations for respiratory diseases during the first COVID-19 wave in Greece","volume":"100","author":"Kyriakopoulos","year":"2021","journal-title":"Respiration"},{"key":"2024101712192036000_10.3.00850-2023.70","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2703"},{"key":"2024101712192036000_10.3.00850-2023.71","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S2213-2600(13)70063-8","article-title":"Smoking cessation in patients with respiratory disease: existing treatments and future directions","volume":"1","author":"Rigotti","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2024101712192036000_10.3.00850-2023.72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604344"},{"key":"2024101712192036000_10.3.00850-2023.73","doi-asserted-by":"publisher","DOI":"10.1136\/thx.52.8.674"},{"key":"2024101712192036000_10.3.00850-2023.74","doi-asserted-by":"crossref","first-page":"e0283949","DOI":"10.1371\/journal.pone.0283949","article-title":"Identification of male COPD patients with exertional hypoxemia who may benefit from long-term oxygen therapy","volume":"18","author":"Garnet","year":"2023","journal-title":"PLoS One"},{"key":"2024101712192036000_10.3.00850-2023.75","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2032911"},{"key":"2024101712192036000_10.3.00850-2023.76","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.22343"},{"key":"2024101712192036000_10.3.00850-2023.77","doi-asserted-by":"crossref","first-page":"107175","DOI":"10.1016\/j.rmed.2023.107175","article-title":"Improved exercise capacity results in a survival benefit after endobronchial valve treatment","volume":"210","author":"Roodenburg","year":"2023","journal-title":"Respir Med"},{"key":"2024101712192036000_10.3.00850-2023.78","doi-asserted-by":"crossref","first-page":"106825","DOI":"10.1016\/j.rmed.2022.106825","article-title":"Survival in COPD patients treated with bronchoscopic lung volume reduction","volume":"196","author":"Hartman","year":"2022","journal-title":"Respir Med"},{"key":"2024101712192036000_10.3.00850-2023.79","first-page":"60","article-title":"Does bronchoscopic lung volume reduction reduce mortality in patients with severe emphysema?","volume":"31","author":"Turan","year":"2021","journal-title":"J Coll Physicians Surg Pak"},{"key":"2024101712192036000_10.3.00850-2023.80","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805800"},{"key":"2024101712192036000_10.3.00850-2023.81","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(16)30069-1","article-title":"Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial","volume":"387","author":"Vestbo","year":"2016","journal-title":"Lancet"},{"key":"2024101712192036000_10.3.00850-2023.82","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12931-018-0874-0","article-title":"Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT\u00ae trial","volume":"19","author":"Tashkin","year":"2018","journal-title":"Respir Res"},{"key":"2024101712192036000_10.3.00850-2023.83","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200906-0876OC"},{"key":"2024101712192036000_10.3.00850-2023.84","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.136077"},{"key":"2024101712192036000_10.3.00850-2023.85","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01230-2018"},{"key":"2024101712192036000_10.3.00850-2023.86","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMe1716802","article-title":"Making sense of triple inhaled therapy for COPD","volume":"378","author":"Suissa","year":"2018","journal-title":"N Engl J Med"},{"key":"2024101712192036000_10.3.00850-2023.87","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01848-2018"},{"key":"2024101712192036000_10.3.00850-2023.88","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1164\/rccm.202006-2618OC","article-title":"Reduced all-cause mortality in the ETHOS trial of budesonide\/glycopyrrolate\/formoterol for chronic obstructive pulmonary disease. A randomized, double-blind, multicenter, parallel-group study","volume":"203","author":"Martinez","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101712192036000_10.3.00850-2023.89","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2147\/COPD.S350167","article-title":"A pooled analysis of mortality in patients with COPD receiving dual bronchodilation with and without additional inhaled corticosteroid","volume":"17","author":"Miravitlles","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024101712192036000_10.3.00850-2023.90","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12890-023-02533-1","article-title":"Smoking cessation after diagnosis of COPD is associated with lower all-cause and cause-specific mortality: a nationwide population-based cohort study of South Korean men","volume":"23","author":"Doo","year":"2023","journal-title":"BMC Pulm Med"},{"key":"2024101712192036000_10.3.00850-2023.91","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.arbres.2022.09.014","article-title":"When and when not to prescribe home oxygen in COPD","volume":"59","author":"Lacasse","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"2024101712192036000_10.3.00850-2023.92","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.37765\/ajmc.2021.88743","article-title":"Noninvasive ventilation at home reduces mortality in COPD with CRF","volume":"27","author":"Frazier","year":"2021","journal-title":"Am J Manag Care"},{"key":"2024101712192036000_10.3.00850-2023.93","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02460-2018"},{"key":"2024101712192036000_10.3.00850-2023.94","first-page":"CD005305","article-title":"Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease","volume":"1","author":"Puhan","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"2024101712192036000_10.3.00850-2023.95","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2020.5230"},{"key":"2024101712192036000_10.3.00850-2023.96","doi-asserted-by":"crossref","first-page":"20406223211014028","DOI":"10.1177\/20406223211014028","article-title":"Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction","volume":"14","author":"Celi","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"2024101712192036000_10.3.00850-2023.97","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.2147\/COPD.S210555","article-title":"Assessment of changes in regional xenon-ventilation, perfusion, and ventilation-perfusion mismatch using dual-energy computed tomography after pharmacological treatment in patients with chronic obstructive pulmonary disease: visual and quantitative analysis","volume":"14","author":"Hwang","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024101712192036000_10.3.00850-2023.98","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12931-022-01949-3","article-title":"Effect of indacaterol\/glycopyrronium on ventilation and perfusion in COPD: a randomized trial","volume":"23","author":"Singh","year":"2022","journal-title":"Respir Res"},{"key":"2024101712192036000_10.3.00850-2023.99","doi-asserted-by":"crossref","first-page":"e210147","DOI":"10.1148\/ryct.210147","article-title":"PREFUL MRI depicts dual bronchodilator changes in COPD: a retrospective analysis of a randomized controlled trial","volume":"4","author":"Voskrebenzev","year":"2022","journal-title":"Radiol Cardiothorac Imaging"},{"key":"2024101712192036000_10.3.00850-2023.100","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2147\/COPD.S313498","article-title":"CONQUEST quality standards: for the collaboration on quality improvement initiative for achieving excellence in standards of COPD care","volume":"16","author":"Pullen","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00850-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:34:25Z","timestamp":1740375265000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00850-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":100,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,6,17]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1183\/23120541.00850-2023"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00850-2023","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]}}}